Literature DB >> 9874471

The National Cancer Data Base report on endometrial carcinoma in African-American women.

M L Hicks1, J L Phillips, G Parham, N Andrews, W B Jones, H M Shingleton, H R Menck.   

Abstract

BACKGROUND: Although the incidence of uterine carcinoma is lower among African-American women compared with white women, the mortality rates are higher for African-American patients. This report is part of an ongoing series on gynecologic malignancies in African-American women.
METHODS: Hospital registry reports collected by the National Cancer Data Base were used to describe some of the differences in case presentation and management characteristics of endometrial carcinoma in these two groups. The cases represented 52,307 Non-Hispanic white and 3226 African-American women diagnosed with primary carcinoma of the endometrium between 1988-1994.
RESULTS: More African-American patients were diagnosed with less favorable histologies than white patients, at more advanced stages of disease, and with less tumor differentiation. Income had no effect on stage or grade. African-American patients were treated less often for their tumor at every stage of diagnosis compared with white women. Income generally had no effect on whether treatment was provided, but limited income was associated with a lack of treatment in African-American patients with American Joint Committee on Cancer Stage IV tumors. African-American women were less frequently treated surgically and, among surgically treated patients at advanced stages of disease, they received adjuvant radiotherapy less often and chemotherapy more often than white patients. Five-year survival was poorer for African-American women, even for patients with the more favorable Stage I adenocarcinoma who were treated surgically.
CONCLUSIONS: All patients, regardless of race, should be treated appropriately as dictated by medical and prognostic factors and not by race. Although no screening methods currently exist for endometrial carcinoma, the development of procedures for identifying patients at risk for the prognostic factors that lead to a poor outcome should be a primary focus.

Entities:  

Mesh:

Year:  1998        PMID: 9874471     DOI: 10.1002/(SICI)1097-0142(19981215)83:12<2629::AID-CNCR30>3.0.CO;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

Review 1.  Racial and ethnic disparities in cancers of the uterine corpus.

Authors:  O W Stephanie Yap; Roland P Matthews
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

2.  Racial disparities in young women with endometrial cancer.

Authors:  Barenya Mukerji; Caitlin Baptiste; Ling Chen; Ana I Tergas; June Y Hou; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2018-01-05       Impact factor: 5.482

3.  The influence of comorbid conditions on racial disparities in endometrial cancer survival.

Authors:  Julie J Ruterbusch; Rouba Ali-Fehmi; Sara H Olson; Shawnita Sealy-Jefferson; Benjamin A Rybicki; Sharon Hensley-Alford; Mohamed A Elshaikh; Arthur R Gaba; Daniel Schultz; Adnan R Munkarah; Michele L Cote
Journal:  Am J Obstet Gynecol       Date:  2014-06-19       Impact factor: 8.661

Review 4.  Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.

Authors:  Yvonne Collins; Kevin Holcomb; Eloise Chapman-Davis; Dineo Khabele; John H Farley
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

5.  Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.

Authors:  Ashley S Felix; David E Cohn; Theodore M Brasky; Richard Zaino; Kay Park; David G Mutch; William T Creasman; Premal H Thaker; Joan L Walker; Richard G Moore; Shashikant B Lele; Saketh R Guntupalli; Levi S Downs; Christa I Nagel; John F Boggess; Michael L Pearl; Olga B Ioffe; Marcus E Randall; Louise A Brinton
Journal:  Am J Obstet Gynecol       Date:  2018-08-07       Impact factor: 8.661

6.  Impact of hospital volume on racial disparities and outcomes for endometrial cancer.

Authors:  Ama Buskwofie; Yongmei Huang; Ana I Tergas; June Y Hou; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2018-03-02       Impact factor: 5.482

7.  Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?

Authors:  G Larry Maxwell; Chunqiao Tian; John I Risinger; Chad A Hamilton; Richard R Barakat
Journal:  Cancer       Date:  2008-09-15       Impact factor: 6.860

Review 8.  Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.

Authors:  B Long; F W Liu; R E Bristow
Journal:  Gynecol Oncol       Date:  2013-05-23       Impact factor: 5.482

9.  Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.

Authors:  John H Farley; Chunqiao Tian; G Scott Rose; Carol L Brown; Michael Birrer; John I Risinger; J Tate Thigpen; Gini F Fleming; Holly H Gallion; G Larry Maxwell
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

10.  Prognostic significance of mucinous differentiation of endometrioid adenocarcinoma of the endometrium.

Authors:  Vijaya Galic; Maria B Schiavone; Thomas J Herzog; Kevin Holcomb; Sharyn N Lewin; Yu-Shiang Lu; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Cancer Invest       Date:  2013-08       Impact factor: 2.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.